ClinConnect ClinConnect Logo
Search / Trial NCT05909566

Respiratory Support and Treatment for Efficient and Cost-Effective Care

Launched by CHRISTOPHER HORVAT · Jun 11, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called REST EEC, is exploring how to improve the care of young children with bronchiolitis, which is a common respiratory illness. The goal is to see if using a special decision support system can help doctors follow a standard approach for starting and stopping a particular treatment called heated high flow nasal cannula (HHFNC), which provides extra oxygen. By doing this, the trial hopes to speed up recovery for kids, reduce unnecessary healthcare costs, and show how UPMC Children's Hospital of Pittsburgh leads in pediatric healthcare.

To participate in this study, children must be under 2 years old and have a specific breathing difficulty score. However, children with weakened immune systems, chronic lung diseases, or certain heart conditions won't be eligible. If your child takes part, they will receive care according to the study's guidelines, which aim to improve their outcomes. This trial is currently looking for participants, so it's a great opportunity to contribute to important research that could benefit many children with bronchiolitis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • \<2 years of age Bronchiolitis WOB Score \>2
  • Exclusion Criteria:
  • Immunocompromised
  • Immunosuppressed
  • Chronic lung disease
  • Congenital heart disease with baseline cardiorespiratory manifestations

About Christopher Horvat

Christopher Horvat is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, he oversees the design, implementation, and management of clinical studies that adhere to the highest ethical and regulatory standards. Leveraging a collaborative approach, Horvat engages with multidisciplinary teams to ensure rigorous data collection and analysis, ultimately striving to bring new treatments to market efficiently and effectively. His expertise in clinical operations and passion for science drive the success of the trials he sponsors, making a meaningful impact in the healthcare landscape.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Christopher Horvat, MD

Principal Investigator

UPMC Children's Hospital of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported